The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Each year, high school students can nominate one another to organize teams that compete to raise money over a seven-week ...

Sergey Shevkoplyas, a professor of biomedical engineering at University of Houston, is leading a team developing new devices for treating children with hyperleukocytosis, a condition that develops ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children, paving ...

Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...